# phase3-clinical-trial-analysis

This is the statistical analysis of a Phase III randomized control clinical trial data. The aim is to assess the efficiency of a new hypertension drug - CardioX (Drug A) - against an active comparator (Drug B) and placebo. Additionally, risk base monitoring (RBM) will be conducted
